Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Form 8 (OPD)

10 Apr 2017 10:11

RNS Number : 0515C
Element Materials Tech Group Ltd
10 April 2017
Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Element Materials Technology Group Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Exova Group plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

7 April 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

Β 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

Β 

TOTAL:

Nil

0

Nil

0

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

None.

Details, including nature of the rights concerned and relevant percentages:

None.

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

None.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

10 April 2017

Contact name:

Jo Wetz

Telephone number:

+44 (0)2035 401 823

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FEEURRKRBWASARR
Date   Source Headline
28th Mar 201711:45 amRNSForm 8.5 (EPT/RI) Exova Group Plc
28th Mar 201711:16 amRNSForm 8.5 (EPT/RI)
28th Mar 201711:00 amRNSForm 8.5 (EPT/RI)
28th Mar 201710:33 amRNSForm 8.3 - Exova Group plc
28th Mar 20177:00 amBUSForm 8.3 - Exova Group Plc
27th Mar 20173:12 pmBUSForm 8.3 - Exova Group Plc
27th Mar 20173:05 pmRNSForm 8.3 - Exova Group Plc
27th Mar 201710:37 amRNSForm 8.3 - Exova Group PLC
27th Mar 20179:15 amRNSRule 2.9 Announcement
27th Mar 20177:00 amRNSPossible Offer for Exova Group plc
28th Feb 20177:00 amRNSFinal Results
12th Jan 20177:00 amRNSPost-close Trading Update
21st Dec 201612:06 pmRNSChanges to Nomination Committee
6th Dec 20167:02 amRNSDevelopment of global laboratory portfolio
1st Dec 20163:15 pmRNSVoting Rights and Capital
29th Nov 20169:00 amRNSDirector/PDMR Shareholding
24th Nov 20169:00 amRNSIssue of Equity
24th Nov 20169:00 amRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSDivisional Reporting of Historic Results
24th Nov 20167:00 amRNSTrading Statement
27th Oct 20164:35 pmRNSPrice Monitoring Extension
24th Oct 20168:51 amRNSTR-1: Notification of Major Interest in Shares
21st Oct 20169:27 amRNSTR-1: Notification of Major Interest in Shares
4th Oct 20164:35 pmRNSPrice Monitoring Extension
21st Sep 20167:00 amRNS2016 Capital Markets Day
13th Sep 20169:00 amRNSTR-1: Notification of Major Interest in Shares
31st Aug 20167:00 amRNSHalf-year Report
21st Jul 20164:40 pmRNSSecond Price Monitoring Extn
21st Jul 20164:35 pmRNSPrice Monitoring Extension
4th Jul 20167:00 amRNSExova acquires Jones Environmental Forensics
1st Jul 20167:00 amRNSExova completes sale of Food, Water & Pharma Biz
29th Jun 20163:07 pmRNSNotice of Results and Capital Markets Day
28th Jun 20164:40 pmRNSSecond Price Monitoring Extn
28th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20168:00 amRNSDirector Declaration
19th May 20161:46 pmRNSResult of AGM
19th May 20161:39 pmRNSAGM Statement
19th May 20167:00 amRNSExova sells UK & Ire Food, Water & Pharma Business
19th May 20167:00 amRNSTrading Update
10th May 20169:00 amRNSDirector/PDMR Shareholding
5th May 201610:00 amRNSIssue of Equity
5th May 201610:00 amRNSDirector/PDMR Shareholding
22nd Apr 20162:00 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Apr 20162:00 pmRNSDirector/PDMR Shareholding
11th Apr 20169:43 amRNSAnnual Report & Accounts 2015 & Notice of 2016 AGM
1st Apr 20169:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
9th Mar 20169:00 amRNSDirector/PDMR Shareholding
7th Mar 20169:00 amRNSDirector/PDMR Shareholding
3rd Mar 20167:00 amRNSFinal Results
18th Feb 201610:16 amRNSDisclosure of Home Member State

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.